EXPRESSION OF ENDOTHELIN AND ET(B) RECEPTORS IN THE MEGAKARYOBLASTIC MEG-01 CELL-LINE

被引:0
|
作者
HAMROUN, D [1 ]
MATHIEU, MN [1 ]
CLAIN, E [1 ]
GERMANI, E [1 ]
LALIBERTE, MF [1 ]
LALIBERTE, MF [1 ]
CHEVILLARD, C [1 ]
机构
[1] FAC PHARM MONTPELLIER,INSERM,U300,F-34060 MONTPELLIER 01,FRANCE
关键词
MEG-01; ENDOTHELIN; ET(A); ET(B);
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The presence of endothelin (ET) receptors and the nature of the subtype and expression of ET were investigated in the human megakaryoblastic cell line MEG-01. By the RT-PCR procedure, we have shown that both ET(A) and ET(B) receptor subtype mRNAs are expressed in the cells. However, binding experiments have shown that the selective ET(B) receptor antagonist BQ788, but not the selective ET(A) receptor antagonist BQ123, competes with the specific binding of [I-125]ET-1. Using immunocytochemistry, RIA, and RT-PCR Southern blot, we have shown that MEG-01 cells express ET-1. In addition, ET (1-21)-like immunoreactivity was released from the cells into the culture medium, and this release was modulated by thrombin. These data suggest that an ET-1-mediated autocrine loop could occur in the human megakaryoblastic MEG-01 cell line.
引用
收藏
页码:S156 / S158
页数:3
相关论文
共 49 条
  • [1] VARIED EXPRESSIONS OF RECEPTORS ON THE HUMAN MEGAKARYOBLASTIC CELL-LINE MEG-01 BY MONOCLONAL-ANTIBODIES
    IMAMURA, N
    MTASIWA, DM
    INADA, T
    KURAMOTO, A
    OGURA, M
    SAITO, H
    AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (02) : 154 - 156
  • [2] Protein kinase C isozymes in human megakaryoblastic leukaemia cell line, MEG-01: Possible involvement of the isozymes in the differentiation process of MEG-01 cells
    Nagata, K
    Okano, Y
    Nozawa, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) : 762 - 771
  • [3] Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells
    Liang, Xue
    Kong, Peiyan
    Wang, Jin
    Xu, Yulin
    Gao, Chunfang
    Guo, Guozhen
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 135 (01) : 14 - 21
  • [4] Valproic acid and all trans retinoic acid differentially induce megakaryopoiesis and platelet-like particle formation from the megakaryoblastic cell line MEG-01
    Schweinfurth, N.
    Hohmann, S.
    Deuschle, M.
    Lederbogen, F.
    Schloss, P.
    PLATELETS, 2010, 21 (08) : 648 - 657
  • [5] Acidic NAADP-releasable Ca2+ compartments in the megakaryoblastic cell line MEG01
    Dionisio, Natalia
    Albarran, Letizia
    Lopez, Jose J.
    Berna-Erro, Alejandro
    Salido, Gines M.
    Bobe, Regis
    Rosado, Juan A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2011, 1813 (08): : 1483 - 1494
  • [6] CHARACTERIZATION OF ENDOTHELIN-A (ET(A)) AND ENDOTHELIN-B (ET(B)) RECEPTORS IN CULTURED BOVINE RETINAL PERICYTES
    MCDONALD, DM
    BAILIE, JR
    ARCHER, DB
    CHAKRAVARTHY, U
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (06) : 1088 - 1094
  • [7] Role of mTOR1 and mTOR2 complexes in MEG-01 cell physiology
    Lopez, Esther
    Berna-Erro, Alejandro
    Lopez, Javier J.
    Granados, Maria P.
    Bermejo, Nuria
    Brull, Jose M.
    Salido, Gines M.
    Rosado, Juan A.
    Redondo, Pedro C.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (05) : 969 - 981
  • [8] Endothelin expression in human megakaryoblastic leukemia cell lines and normal platelet precursors
    Mathieu, MN
    Vittet, D
    Laliberte, MF
    Laliberte, F
    Nonotte, I
    Hamroun, D
    Launay, JM
    Chevillard, C
    REGULATORY PEPTIDES, 1997, 68 (02) : 91 - 97
  • [9] SARS-CoV-2 Lysate Stimulation Impairs the Release of Platelet-like Particles and Megakaryopoiesis in the MEG-01 Cell Line
    Lopardo, Valentina
    Montella, Francesco
    Esposito, Roberta Maria
    Zannella, Carla
    Aliberti, Silvana Mirella
    Capunzo, Mario
    Franci, Gianluigi
    Puca, Annibale Alessandro
    Ciaglia, Elena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [10] CHARACTERIZATION OF ENDOTHELIN RECEPTORS ON A HUMAN NEUROBLASTOMA CELL-LINE - EVIDENCE FOR THE ETA-SUBTYPE
    WILKES, LC
    BOARDER, MR
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (03) : 750 - 754